Skip to main content
Loading market data...
ETF NYSE Arca USD

Direxion Daily S&P Biotech Bull 3X ETF LABU

Issuer: Direxion SEC registrant: Direxion Shares ETF Trust Derivatives-based
Watch LABU (sign in) Add to portfolio (LABU) Set an alert for LABU Compare LABU with other ETFs Position size calculator for LABU at 235.99 USD

How position sizing works
Last price 235.99 USD Change: Up +23.20 Percent change: Up +10.90%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
Unavailable
Not found in the fee data
Net assets
$494.4M
As of 31 Jul 2026
Holdings
163
As of 31 Jul 2026
12-month distribution yield
0.39%
Quarterly
Asset class
Derivatives-based
From holdings

Direxion Daily S&P Biotech Bull 3X ETF (LABU) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Direxion. Its category is Derivatives-based. Its last price was US$235.99 on 20 Oct 2026. It reported net assets of US$494.36 million as of 31 Jul 2026. Its latest holdings report lists 163 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.91 a unit, a 12-month distribution yield of 0.39%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

No expense ratio found

This fund's class was not in the SEC prospectus fee data sets for the last five quarters. Check the fund's latest prospectus.

Size and reporting

Net assets
$494,358,533
Total assets
$668,352,070
Holdings as of
31 Jul 2026
Report made public
28 Sep 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 163 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

LABU top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 DREYFUS DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) No identifier reported 15.86% $78.4M Short-term investment vehicles (cash funds) United States USD
2 GOLDMAN FINANCIAL GOLDMAN FINL SQ TRSRY INST 506 No identifier reported 14.83% $73.3M Short-term investment vehicles (cash funds) United States USD
3 S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP No identifier reported 9.63% $47.6M Other derivatives United States USD
4 S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP No identifier reported 7.30% $36.1M Other derivatives United States USD
5 GOLDMAN SACHS LIQ ES FD A GOLDMAN SACHS FIN GOV 465 INSTITUT No identifier reported 5.35% $26.5M Short-term investment vehicles (cash funds) United States USD
6 S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP No identifier reported 4.85% $24.0M Other derivatives United States USD
7 S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP No identifier reported 3.87% $19.2M Other derivatives United States USD
8 APOGEE THERAPEUTICS INC US03770N1019 1.11% $5.5M Equity (common) United States USD
9 ORUKA THERAPEUTICS INC US6876041087 1.03% $5.1M Equity (common) United States USD
10 DIANTHUS THERAPEUTICS INC US2528281080 0.96% $4.7M Equity (common) United States USD
11 ERASCA INC US29479A1088 0.93% $4.6M Equity (common) United States USD
12 TWIST BIOSCIENCE CORP Twist Bioscience Corporation COM USD0.00001 US90184D1000 0.92% $4.6M Equity (common) United States USD
13 KYMERA THERAPEUTICS INC Kymera Therapeutics Inc COM US5015751044 0.90% $4.5M Equity (common) United States USD
14 SPYRE THERAPEUTICS INC US00773J2024 0.89% $4.4M Equity (common) United States USD
15 REVOLUTION MEDICINES INC Revolution Medicines Inc COM US76155X1000 0.89% $4.4M Equity (common) United States USD
16 CG ONCOLOGY INC US1569441009 0.88% $4.4M Equity (common) United States USD
17 PROTAGONIST THERAPEUTICS INC Protagonist Therapeutics Inc COM USD0.00001 US74366E1029 0.88% $4.4M Equity (common) United States USD
18 PRAXIS PRECISION MEDICINES INC US74006W2070 0.87% $4.3M Equity (common) United States USD
19 REGENERON PHARMACEUTICALS INC Regeneron Pharmaceuticals, Inc. COM USD0.001 US75886F1075 0.87% $4.3M Equity (common) United States USD
20 COGENT BIOSCIENCES INC Cogent Biosciences Inc. COM US19240Q2012 0.85% $4.2M Equity (common) United States USD
21 NATERA INC Natera Incorporation COM USD0.0001 US6323071042 0.84% $4.2M Equity (common) United States USD
22 ARROWHEAD PHARMACEUTICALS INC Arrowhead Pharmaceuticals Inc COM USD0.001 US04280A1007 0.82% $4.0M Equity (common) United States USD
23 TRAVERE THERAPEUTICS INC Travere Therapeutics Inc COM US89422G1076 0.82% $4.0M Equity (common) United States USD
24 ROIVANT SCIENCES LTD BMG762791017 0.81% $4.0M Equity (common) Bermuda USD
25 RELAY THERAPEUTICS INC Relay Therapeutics Inc COM US75943R1023 0.81% $4.0M Equity (common) United States USD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 31 Jul 2026

All 163 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Warning: Uses derivatives

Derivative contracts in this report have a combined notional amount of 233% of net assets. The weights here show each contract's reported value, not the exposure it creates.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 67.07%
Short-term investment vehicles (cash funds) 36.04%
Other derivatives 26.32%

Country

Country by weight
CountryWeightBar
United States 125.79%
Ireland 0.84%
Bermuda 0.81%
Netherlands 0.72%
Switzerland 0.66%
British Virgin Islands 0.35%
Cayman Islands 0.14%
Canada 0.11%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 129.43%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 31.49%
Health Technology 1.11%

Partial coverage: sectors are known for 32.6% of net assets (49% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.9100
1 payment per unit
12-month yield
0.39%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
23 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.9100) ÷ latest price ($235.99) × 100 = 0.39%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (9 payments)
LABU distributions per unit by ex-date
Ex-dateAmount per unit
23 Dec 2025$0.9100
23 Sep 2025$0.1030
24 Jun 2025$0.2190
25 Mar 2025$0.1070
25 Jun 2024$0.1500
19 Mar 2024$0.1610
21 Dec 2023$0.2100
19 Sep 2023$0.0400
21 Jun 2023$0.1800

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme